CRF07_BC is associated with slow HIV disease progression in Chinese patients

HIV subtypes convey important epidemiological information and possibly influence the rate of disease progression. In this study, HIV disease progression in patients infected with CRF01_AE, CRF07_BC, and subtype B was compared in the largest HIV molecular epidemiology study ever done in China. A national data set of HIV pol sequences was assembled by pooling sequences from public databases and the Beijing HIV laboratory network. Logistic regression was used to assess factors associated with the risk of AIDS at diagnosis ([AIDSAD], defined as a CD4 count<200 cells/L) in patients with HIV subtype B, CRF01_AE, and CRF07_BC. Of the 20,663 sequences, 9,156 (44.3%) were CRF01_AE. CRF07_BC was responsible for 28.3% of infections, followed by B (13.9%). In multivariable analysis, the risk of AIDSAD differed significantly according to HIV subtype (OR for CRF07_BC vs. B: 0.46, 95% CI 0.390.53), age (OR for >= 65 years vs.<18 years: 4.3 95% CI 1.8111.8), and transmission risk groups (OR for men who have sex with men vs. heterosexuals: 0.67 95% CI 0.60.75). These findings suggest that HIV diversity in China is constantly evolving and gaining in complexity. CRF07_BC is less pathogenic than subtype B, while CRF01_AE is as pathogenic as B.

Automated summary

HIV subtype diversity in China, including CRF01_AE, CRF07_BC, and subtype B, is constantly evolving and gaining complexity. CRF07_BC is less pathogenic than subtype B, while CRF01_AE is as pathogenic as B. Age and transmission risk groups also play a role in the diagnosis and disease progression of AIDS.